Terminology Service < Semantic Lookup Platform

All terms in NCIT

Label	Id	Description
Negative Regulation of Apoptosis	NCIT_C19932	[Any cellular process that decreases the frequency, rate or extent of cell death by apoptosis.]
Genetics and Medicine	NCIT_C15970	[An NIH Emphasis area]
Cancer Control	NCIT_C15971	[Integrated program having an objective of reducing risk, incidence, and mortality from cancer and to enhancing the quality of life for cancer survivors. Realized through an orderly sequence of measures from genetic, epidemiologic, behavioral, social, applied, and surveillance cancer research to the development and implementation of effective interventions, and monitor and analysis of cancer trends in all segments of the population.]
Cancer Intervention	NCIT_C16086
Biological Immunotherapy	NCIT_C15972	[The use of biological agents to enhance the host immune system.]
Immunotoxin Cancer Immunotherapy	NCIT_C15973	[Semisynthetic conjugates of various toxic molecules, including radioactive isotopes and bacterial or plant toxins, with specific immune substances such as immunoglobulins, monoclonal antibodies, and antigens. The antitumor or antiviral immune substance carries the toxin to the tumor or infected cell where the toxin exerts its poisonous effect.]
Biological Cancer Immunotherapy	NCIT_C15974	[The use of biological agents to enhance the host immune system in the treatment of cancer.]
Chemical Cancer Immunotherapy	NCIT_C15975	[Chemical Cancer Immunotherapy is the use of chemical substances to alter the interaction between the host's immune defenses and cancer cells to boost, direct, or restore the body's ability to fight cancer.]
Mouse Tumor Gene Index	NCIT_C15976	[A component of CGAP.]
Uterine Proliferative Phase Alteration	NCIT_C40932	[Uterine Proliferative Phase Alteration involves a change in the existing state of any process involving the uterine lining during the early stage of the menstrual cycle (Proliferative Phase) that may affect endometrial proliferation and alter uterine function.]
Uterine Function Alteration	NCIT_C40931	[Uterine Function Alteration involves a qualitative change in the existing activity of the hollow muscular female organ in which an impregnated ovum develops into a child.]
Vaginal Function Alteration	NCIT_C40933	[Vaginal Function Alteration involves a qualitative change in the existing activity of the female genital canal, extending from the uterus to the vulva.]
Female Reproductive System Alteration	NCIT_C40928	[Female Reproductive System Alteration involves a change in the quality of the existing state of functionality of one or more female reproductive organs or organ processes.]
Repository Operation, Tissue	NCIT_C15978
Male Reproductive System Alteration	NCIT_C40934	[Male Reproductive System Alteration involves a qualitative change in the existing activity of the male reproductive organs, which include the penis, scrotum, urethra, testis, epididymis, ductus deferens, seminal vesicle, ejaculatory duct, prostate, and bulbourethral gland.]
Focused Ultrasound Therapy	NCIT_C15979	[Minimally invasive procedure for ablating tumors. The primary mechanism of tissue damage is thermal.]
Penile Erectile Alteration	NCIT_C40935	[Penile Erectile Alteration involves a change in quality of the ability of the penis to achieve and maintain an erection. Mechanisms of alteration include induction or inhibition of blood flow to the corpus cavernosa and nerve stimuli to the penile musculature.]
Mixed Phenotype Acute Leukemia, Not Otherwise Specified, Rare Subtypes	NCIT_C151990	[A very rare group of mixed phenotype acute leukemias, not otherwise specified in which the blasts show clear-cut evidence of both B-cell and T-cell lineage or evidence of trilineage (B-cell, T-cell, and myeloid lineage) assignment. (WHO 2017)]
Mixed Phenotype Acute Leukemia	NCIT_C82179	[An acute leukemia of ambiguous lineage. It is characterized by the presence of either separate populations of blasts of more than one lineage, or one population of blasts co-expressing markers of more than one lineage.]
Prostatic Alteration	NCIT_C40936	[Prostatic Alteration involves a qualitative change in the existing activity of the accessory sex gland (prostate gland) of the male reproductive system that surrounds the neck of the bladder and urethra and secretes into seminal fluid acid phosphatase, citric acid, and proteolytic enzymes that liquefy coagulated semen.]